(Medical Xpress) -- Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia – a cancer with limited treatment options and relatively poor survival, according to research ...
Mar 30, 2012
0
0
Australian scientists have found what could prove to be a new and effective way to treat a particularly aggressive blood cancer in children.
May 28, 2021
0
4
University of New South Wales researchers have developed a compound that has had a surprise result: being effective in the prevention of asthma.
Jan 22, 2013
1
0
A genomic study of chronic blood cancer - a precursor to leukaemia - has discovered gene mutations that could enable diagnosis using only a blood test, avoiding the need for an invasive and painful bone marrow biopsy.
Sep 26, 2011
0
0
Using fractionated doses of the targeted anticancer drug gemtuzumab ozogamicin allows for safer delivery of the drug into patients aged 50-70 years with acute myeloid leukaemia (AML) and substantially improves their outcomes. ...
Apr 4, 2012
0
0
An experimental treatment that trains a patient's immune system to attack their cancer caused remission in 90 per cent of leukaemia patients on a small-scale trial, though experts warn questions remain.
Oct 17, 2014
0
0
A research team led by scientists from the University of Veterinary Medicine Vienna (Vetmeduni) has taken an important step toward a better understanding of certain difficult-to-treat blood cancers. The researchers have identified ...
Jan 19, 2023
0
22
The key genetic events responsible for initiating the early stages of a type of childhood leukaemia have been identified by scientists at The Institute of Cancer Research, London. Insights into the 'founder' genetic mutation ...
Apr 5, 2018
0
22
Scientists from the Wellcome Sanger Institute and the University of Cambridge found that in children with neuroblastoma—a cancer of immature nerve cells—treatment with platinum chemotherapy caused changes to the genome ...
May 28, 2021
0
4
Studies conducted at the Comprehensive Cancer Center at MedUni Vienna and Vienna General Hospital show that the drugs ibrutinib and idelalisib used in the targeted treatment of chronic lymphatic leukaemia can significantly ...
Mar 16, 2016
0
2
